These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21423198)

  • 41. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction.
    Labairu-Huerta L; Padilla-Fernández B; Arrondo-Arrondo JL; Valverde-Martínez LS; Martín-Rodríguez A; Silva-Abuín JM; García-Cenador MB; Mirón-Canelo JA; Lorenzo-Gómez MF
    Arch Ital Urol Androl; 2015 Sep; 87(3):204-9. PubMed ID: 26428641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials: A Systematic Review and Meta-analysis.
    Stridh A; Pontén M; Arver S; Kirsch I; Abé C; Jensen KB
    JAMA Netw Open; 2020 Mar; 3(3):e201423. PubMed ID: 32196105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
    Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
    Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment.
    Symonds T; Dean JD; Carr A; Carlsson M; Marfatia A; Schnetzler G
    J Sex Med; 2011 May; 8(5):1463-71. PubMed ID: 21324090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue.
    Oger S; Behr-Roussel D; Gorny D; Lecoz O; Lebret T; Denoux Y; Faix A; Leriche A; Wayman C; Alexandre L; Giuliano F
    J Sex Med; 2009 Mar; 6(3):836-47. PubMed ID: 19143907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.
    Watkins Bruner D; James JL; Bryan CJ; Pisansky TM; Rotman M; Corbett T; Speight J; Byhardt R; Sandler H; Bentzen S; Kachnic L; Berk L
    J Sex Med; 2011 Apr; 8(4):1228-38. PubMed ID: 21235716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Summary for patients. Effect of testosterone on response to sildenafil in men with erectile dysfunction.
    Ann Intern Med; 2012 Nov; 157(10):I-18. PubMed ID: 23165675
    [No Abstract]   [Full Text] [Related]  

  • 48. [Combined treatment of patients with erectile dysfunction and urination disorders].
    Kamalov AA; Osmolovskiĭ BE; Okhobotov DA; Khodyreva LA; Takhiradze TB; Takhiradze AM; Gevorkian AR
    Urologiia; 2013; (3):29-30, 32-3. PubMed ID: 23987045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An update on the drug safety of treating erectile dysfunction.
    Gul M; Serefoglu EC
    Expert Opin Drug Saf; 2019 Oct; 18(10):965-975. PubMed ID: 31433252
    [No Abstract]   [Full Text] [Related]  

  • 50. Sildenafil for erectile dysfunction in the Middle East: observational analysis of patients with diabetes and/or hypertension treated in the clinical practice setting.
    El-Sakka AI; Anis T; Khadr N; Ismail TA; Hegazy AM; Fekry O; Youseif E
    J Int Med Res; 2011; 39(2):558-68. PubMed ID: 21672361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder.
    Kennedy SH; Dugré H; Defoy I
    Int Clin Psychopharmacol; 2011 May; 26(3):151-8. PubMed ID: 21471773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viability and safety of combination drug therapies for erectile dysfunction.
    Steers WD
    J Urol; 2003 Aug; 170(2 Pt 2):S20-3; discussion S23. PubMed ID: 12853768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Optimization of the use of phosphodiesterase-5 inhibitors].
    Pushkar' DIu; Segal AS
    Urologiia; 2012; (4):79-80, 82. PubMed ID: 23116030
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal.
    Mostafa T; Hassan A; Alghobary MF; Abdelrahman SH
    Sex Med Rev; 2020 Oct; 8(4):573-585. PubMed ID: 32636154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Hatzimouratidis K; Salonia A; Adaikan G; Buvat J; Carrier S; El-Meliegy A; McCullough A; Torres LO; Khera M
    J Sex Med; 2016 Apr; 13(4):465-88. PubMed ID: 27045254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction.
    Mydlo JH; Volpe MA; MacChia RJ
    BJU Int; 2000 Sep; 86(4):469-73. PubMed ID: 10971274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy.
    Mydlo JH; Volpe MA; Macchia RJ
    Eur Urol; 2000 Jul; 38(1):30-4. PubMed ID: 10859438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors.
    Garrido Abad P; Sinués Ojas B; Martínez Blázquez L; Conde Caturla P; Fernández Arjona M
    Actas Urol Esp; 2015 Dec; 39(10):635-40. PubMed ID: 26049734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors.
    Jannini EA; DeRogatis LR; Chung E; Brock GB
    J Sex Med; 2012 Jan; 9(1):26-33. PubMed ID: 22221307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and medical management of erectile dysfunction in Asia.
    Park K; Hwang EC; Kim SO
    Asian J Androl; 2011 Jul; 13(4):543-9. PubMed ID: 21460862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.